INNAVIRVAX
4Patents
4Active
4Granted
43Portfolio score
Filing activity: Apr 13, 2012 → Sep 22, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9511136B2 | Immunogenic compounds comprising HIV GP41 peptide coupled to CRM197 carrier protein | Chemistry; Metallurgy | 0 | Active |
| US9802983B2 | Compositions for preventing and/or treating an infection by an HIV-1 virus | Physics | 0 | Active |
| US9181299B2 | Compositions for detecting an infection by an HIV-1 virus | Physics | 0 | Active |
| US10174080B2 | Compositions for preventing and/or treating an infection by an HIV-1 virus | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.